The work was based on testing of 70 volunteers, with the Flinders ophthalmology and medical device research institute experts taking a novel approach with optical coherence tomography (OCT), a device already available in most optometric and all ophthalmic practices.
‘OCT could help monitor and detect the effects of myopia, which could make the system suitable for use in regular clinical practice.’
“This may help monitor, measure, and explore the effects of myopia and how it leads to vision loss,” he says, adding further development could make the system suitable for use in regular clinical practice.
Prior research elsewhere with MRI scanning has demonstrated large scale irregularities in the eyeball in highly myopic eyes.
OCT can sample the shape of the eye on a much smaller scale than MRI. The OCT testing will be far cheaper, is more readily available and repeatable as a test, researchers say in the article.
Myopia (short or near-sightedness) is for many an inconvenience requiring glasses or contact lens to correct. However, globally it is an epidemic and a major cause of vision loss and sometimes blindness.
Myopia is defined practically by the strength of lens required to correct eyesight. It was already known myopia relates very strongly to the size/length of the eyeball.
Global estimates forecast up to 5 billion people will have myopia and 1 billion people could suffer with high myopia by 2050, placing a significant burden on health systems to manage and prevent myopia-related ocular complications and vision loss.
This seven-fold increase, between 2000 and 2050, would make myopia the leading cause of permanent blindness worldwide (source – Holden et al ‘Global Myopia Trends 2000-2050’).
High myopia increases the risk of pathological ocular changes such as cataract, glaucoma, retinal detachment and myopic macular degeneration – all of which cause irreversible vision loss
The post appeared first on http://feeds.feedburner.com/allhealthnews